Effects of the β-adrenoceptor Antagonists Atenolol and Propranolol on Human Parotid and Submandibular-Sublingual Salivary Secretion

Abstract

The aim of the study was to evaluate the effects of a β₁-selective (atenolol 50 mg q.d.) and a non-selective (propranolol 80 mg b.i.d.) p-adrenoceptor antagonist on human stimulated parotid and submandibular-sublingual (SM-SL) gland secretion. A randomized double-blind, placebo-controlled cross-over ("Latin square") design was used in 19 healthy male volunteers. Stimulated parotid and SM-SL saliva were sampled immediately before and 7 days after the start of each treatment period. Stimulation of salivary secretion was achieved by use of a 3% citric acid solution. Plasma concentrations of propranolol and atenolol were determined from blood samples. The salivary secretion of both glands was assessed for flow rate, amylase, lysozyme, and salivary peroxidase activity and for concentrations of total protein, hexosamine, sialic acid, Ca²⁺, Cl^-, K⁺, Mg²⁺, Na⁺, and PO₄ ^3-. In both parotid and SM-SL secretions, the total protein and phosphate concentrations and amylase activity were significantly decreased during the two active treatment periods. In SM-SL gland secretion, there were significant changes in potassium and calcium concentrations during active treatment as compared with baseline, with potassium showing a decreased and calcium an increased concentration. During atenolol treatment, salivary peroxidase activity decreased significantly in SM-SL secretion. In parotid secretion, the hexosamine/total protein ratio decreased and the sialic acid/hexosamine ratio increased during atenolol treatment, which may indicate an effect on protein synthesis. No significant effects on salivary secretion rates were disclosed.

Keywords

(3-adrenergic Receptor Antagonists Salivary Glands Submandibular Saliva.

Get full access to this article

View all access options for this article.

References

Ablad B. , Abrahamsson T. , Hultberg E. , Majcherczyk S. , Nerme V. , Sjolander M. (1984). Pharmakologische Grundlagen. In: β-Rezeptorblockade. Die klinische Bedeutung der β1-Selektivität. Lohmann FW , editor. München: Verlag für angewandte Wissenschaf ten, pp. 11-32.

Baum BJ ( 1987). Neurotransmittor control of secretion. JDent Res 66 :628-632.

Blix G. ( 1948). The determination of hexosamine according to Elson and Morgan. Acta Chem Scand 2:467-473.

Block PL , Brottman BS (1962). A method of submaxillary saliva collection without cannulation. NY State Dent J 28:116-118.

Carlson AJ , Crittenden AC (1910). The relation of ptyalin concentration to the diet and to the rate of secretion of saliva. Am J Physiol 26:169-177.

Gothef ors L. , Marklund S. (1975). Lactoperoxidase activity in human milk and saliva of newborn infants. Infect Immun 11:1210-1215.

Henriksson R. (1982). β1 and β2 adrenoceptor agonists have different effects on rat parotid cells. Am J Physiol 242:G481-G485.

Jensen JL , Brodin P. , Berg T. , Aars H. ( 1991). Parotid secretion of fluid, amylase and kallikrein during reflex stimulation under normal conditions and af ter acute administration of autonomic blocking agents in man. Acta Physiol Scand 143:321-329.

Jirakulsomchok D. , Schneyer CA (1984). Effects of adrenergic agonists on electrolyte transport in perfused salivary duct of rat. J Autonom Nerv Syst 11:233-241.

10.

Jirakulsomchok D. , Schneyer CA (1987a). Effects of α, β1 and β2 adrenergic antagonists on the Na and K concentrations of sympathetic-nerve stimulated rat saliva. J Autonom Nerv Syst 20:65-71.

11.

Jirakulsomchok D. , Schneyer CA (1987b). Effects of sympathetic nerve stimulation in the presence of specific adrenergic antagonists on Na, K and Cl transport in perfused rat submandibular duct. J Autonom Nerv Syst 19:255-259.

12.

Johnson DA , Cortez JE (1988). Chronic treatment with beta adrenergic agonists and antagonists alters the composition of proteins in rat parotid saliva. J Dent Res 67:1103-1108.

13.

Laurikainen K. , Laurikainen E. , TenovuoJ, Kaila T. , Vilja P. (1988). Effects of a β-blocking agent, timolol maleate, on saliva in healthy volunteers . Scand J Dent Res 96:121-127.

14.

Lowry OH , Rosebrough NR , Farr AL , Randall RJ (1951). Protein measurement with the folin phenol reagent . J Biol Chem 193:265-275.

15.

Mandel ID , Katz R. ( 1968). The effect of pharmacologic agents on salivary secretion and composition. II. Isoproteronol, alpha and beta adrenergic blockers. J Oral Ther Pharmacol 4:260-269.

16.

Murphy J. , Riley JP (1962). A modified single solution method for the determination of phosphate in natural water. Anal Chim Acta 27 :31-36.

17.

Nederfors T. , Dahlof C. (1992). Effects of the p-adrenoceptor antagonists atenolol and propranolol on human whole saliva flow rate and composition. Arch Oral Biol 37:579-584.

18.

Nederf ors T. , Dahlof C. (1993). A modified device for collection and flow rate measurements of submandibular-sublingual saliva. Scand J Dent Res 101:210-214.

19.

Nederfors T. , Twetman S. , Dahlof C. (1989). Effects of the thiazide diuretic bendrof lumethiazide on salivary flow rate and composition. Scand J Dent Res 97:520-527.

20.

Nederfors T. , Henricsson V. , Axell T. , Dahlof C. (1993). Oral mucosal friction and subjective perception of dry mouth in relation to salivary secretion. Scand J Dent Res 101:44-48.

21.

Parvinen T. , Parvinen I. , Larmas M. (1984). Stimulated salivary flow rate, pH and lactobacillus and yeast concentrations in medicated persons. Scand J Dent Res 92:524-532.

22.

Ryberg M. , Moller C. , Ericson T. (1991). Saliva composition and caries development in patients treated with β2-adrenoceptor agonists:a 4-year follow up study. Scand J Dent Res 99:212-218.

23.

Schneyer CA (1986). Calcium levels in rat submandibular gland and saliva after sympathetic nerve stimulation in the presence of a, β1 and β2-adrenergic antagonists. Arch Oral Biol 31:383-386.

24.

Schneyer CA , Humphreys-Beher MG (1987). β-adrenergic and muscarinic receptor densities of rat submandibular main duct. Proc Soc Exp Biol Med 185:81-83.

25.

Schneyer CA , Yu J-H. , Jirakulsomchok D. (1985). Modification of dobutamine- and terbutaline-induced calcium and fluid secretion from rat salivary glands by atenolol and butoxamine . J Autonom Nerv Syst 13:275-285.

26.

Sreebny LM , Schwartz SS (1986). A reference guide to drugs and dry mouth. Gerodontology 5:79-86.

27.

Sreebny LM , Valdini A. (1989). Xerostomia part II: relationship to nonoral symptoms, drugs and diseases. Oral Surg Oral Med Oral Pathol 68:419-427.

28.

Streckfus CF , Welsh S. , Strahl RC (1991). Diminution of parotid IgA secretion in an elderly black population taking antihypertension medications. Oral Surg Oral Med Oral Pathol 71 :50-54.

29.

Warren L. (1959). The thiobarbituric acid assay of sialic acids . J Biol Chem 234:1971-1975.

30.

Watson GE , Pearson SK , Falany JL , Tabak LA , Bowen WH (1990). The effect of chronic propranolol treatment on salivary composition and caries in the rat. Arch Oral Biol 35:435-441.

31.

Yu J-H. , Schneyer CA (1984). Effect of a- and p-adrenergic agonists on fluid and calcium secretion by rat salivary glands. Arch Oral Biol 29:141-146.